Omron Healthcare begins production at first India plant
Omron Healthcare, the medical-device arm of Japan's Omron, has commenced full-scale blood pressure monitor production at its first Indian manufacturing…
All articles by BV Swagath
BV Swagath
-
-
J&J data show lower mortality with Impella in HRPCI than CHIP-BCIS3
Johnson & Johnson (J&J) has reported findings from three separate clinical analyses demonstrating reduced mortality among high-risk percutaneous coronary intervention…
-
Firefly to offer NeuroSigma’s non-drug ADHD device to clinicians
Firefly Neuroscience has struck a partnership with bioelectronic device maker NeuroSigma to broaden clinician reach for the latter’s Monarch eTNS…
-
Accuray partners with Samsung NeuroLogica on CyberKnife imaging
Radiation therapy technology company Accuray has entered into agreements with Samsung NeuroLogica to pursue advanced volumetric imaging capabilities for its…
-
Pulnovo Medical enrols first US patients in PULSE-LHD IDE trial
Pulnovo Medical has enrolled the first two US patients in its PULSE-LHD clinical trial, evaluating pulmonary artery denervation (PADN) for…
-
Shape Memory Medical secures $10m to advance aortic clinical trials
Shape Memory Medical has raised $10m in convertible note financing led by August Global Partners, joined by new investor Taiwania…
-
Co-Diagnostics files FDA 510(k) for flu and RSV PCR test
Co-Diagnostics has filed a Dual 510(k) premarket notification with the US Food and Drug Administration (FDA) for its Co-Dx PCR…
-
Health Canada approves Kardium’s Globe pulsed field system
Health Canada has granted a Medical Device Licence for the Globe pulsed field system, an integrated cardiac mapping and ablation…
-
Neusoft Medical introduces NeuViz P10 PCCT system in China
Neusoft Medical Systems has launched its NeuViz P10 photon-counting CT (PCCT) system in China, targeting advanced medical imaging applications. This…
-
Natera’s Signatera test to be used in Phase III bladder cancer trial
US-based clinical genetic testing company Natera said that its Signatera test will be utilised in the newly activated ARCHER trial,…